Free Trial

Mind Medicine (MindMed) (MNMD) Competitors

Mind Medicine (MindMed) logo
$12.47 +0.04 (+0.32%)
Closing price 04:00 PM Eastern
Extended Trading
$12.50 +0.03 (+0.25%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

MNMD vs. CRNX, GMTX, LNTH, VKTX, PRAX, MIRM, TLX, ACAD, QURE, and ADMA

Should you be buying Mind Medicine (MindMed) stock or one of its competitors? The main competitors of Mind Medicine (MindMed) include Crinetics Pharmaceuticals (CRNX), Gemini Therapeutics (GMTX), Lantheus (LNTH), Viking Therapeutics (VKTX), Praxis Precision Medicines (PRAX), Mirum Pharmaceuticals (MIRM), Telix Pharmaceuticals (TLX), ACADIA Pharmaceuticals (ACAD), uniQure (QURE), and ADMA Biologics (ADMA). These companies are all part of the "pharmaceutical products" industry.

Mind Medicine (MindMed) vs. Its Competitors

Crinetics Pharmaceuticals (NASDAQ:CRNX) and Mind Medicine (MindMed) (NASDAQ:MNMD) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, media sentiment, earnings, institutional ownership, analyst recommendations, risk, valuation and profitability.

Crinetics Pharmaceuticals currently has a consensus price target of $74.45, indicating a potential upside of 85.76%. Mind Medicine (MindMed) has a consensus price target of $27.83, indicating a potential upside of 123.20%. Given Mind Medicine (MindMed)'s stronger consensus rating and higher possible upside, analysts plainly believe Mind Medicine (MindMed) is more favorable than Crinetics Pharmaceuticals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Crinetics Pharmaceuticals
1 Sell rating(s)
2 Hold rating(s)
11 Buy rating(s)
0 Strong Buy rating(s)
2.71
Mind Medicine (MindMed)
1 Sell rating(s)
0 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
3.00

Mind Medicine (MindMed) has lower revenue, but higher earnings than Crinetics Pharmaceuticals. Crinetics Pharmaceuticals is trading at a lower price-to-earnings ratio than Mind Medicine (MindMed), indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Crinetics Pharmaceuticals$1.04M3,629.55-$298.41M-$4.11-9.75
Mind Medicine (MindMed)N/AN/A-$108.68M-$1.53-8.15

Crinetics Pharmaceuticals has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Comparatively, Mind Medicine (MindMed) has a beta of 2.55, meaning that its share price is 155% more volatile than the S&P 500.

Crinetics Pharmaceuticals' return on equity of -32.28% beat Mind Medicine (MindMed)'s return on equity.

Company Net Margins Return on Equity Return on Assets
Crinetics PharmaceuticalsN/A -32.28% -29.45%
Mind Medicine (MindMed) N/A -50.24%-39.41%

98.5% of Crinetics Pharmaceuticals shares are held by institutional investors. Comparatively, 27.9% of Mind Medicine (MindMed) shares are held by institutional investors. 4.6% of Crinetics Pharmaceuticals shares are held by company insiders. Comparatively, 2.5% of Mind Medicine (MindMed) shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Mind Medicine (MindMed) had 1 more articles in the media than Crinetics Pharmaceuticals. MarketBeat recorded 5 mentions for Mind Medicine (MindMed) and 4 mentions for Crinetics Pharmaceuticals. Crinetics Pharmaceuticals' average media sentiment score of 1.84 beat Mind Medicine (MindMed)'s score of 0.91 indicating that Crinetics Pharmaceuticals is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Crinetics Pharmaceuticals
2 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Mind Medicine (MindMed)
0 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Mind Medicine (MindMed) beats Crinetics Pharmaceuticals on 8 of the 15 factors compared between the two stocks.

Get Mind Medicine (MindMed) News Delivered to You Automatically

Sign up to receive the latest news and ratings for MNMD and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding MNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

MNMD vs. The Competition

MetricMind Medicine (MindMed)MED IndustryMedical SectorNASDAQ Exchange
Market Cap$945.77M$3.44B$6.19B$10.60B
Dividend YieldN/A2.26%5.72%4.86%
P/E Ratio-8.158.2221.1124.06
Price / SalesN/A477.59577.46128.87
Price / CashN/A44.5736.5560.64
Price / Book3.8810.3512.076.53
Net Income-$108.68M-$52.53M$3.32B$276.75M
7 Day Performance4.70%-0.22%-0.16%0.20%
1 Month Performance25.33%10.89%5.76%1.67%
1 Year Performance100.48%14.19%65.71%32.73%

Mind Medicine (MindMed) Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
MNMD
Mind Medicine (MindMed)
3.4248 of 5 stars
$12.47
+0.3%
$27.83
+123.2%
+97.0%$945.77MN/A-8.1540
CRNX
Crinetics Pharmaceuticals
4.333 of 5 stars
$42.45
+2.1%
$74.45
+75.4%
-32.2%$4.00B$1.04M-10.33210
GMTX
Gemini Therapeutics
N/A$89.94
+21.0%
N/A+69.2%$3.90BN/A-89.9430High Trading Volume
LNTH
Lantheus
4.5894 of 5 stars
$56.60
+1.8%
$74.50
+31.6%
-49.3%$3.85B$1.53B15.05700Trending News
VKTX
Viking Therapeutics
3.9731 of 5 stars
$33.75
+0.7%
$86.42
+156.0%
-49.3%$3.79BN/A-22.0620News Coverage
Earnings Report
Analyst Downgrade
Gap Up
PRAX
Praxis Precision Medicines
2.4873 of 5 stars
$175.07
-7.9%
$222.36
+27.0%
+155.3%$3.71B$8.55M-14.24110Trending News
Analyst Forecast
Analyst Revision
High Trading Volume
MIRM
Mirum Pharmaceuticals
3.8919 of 5 stars
$73.03
-0.7%
$79.70
+9.1%
+75.4%$3.67B$336.89M-60.35140
TLX
Telix Pharmaceuticals
3.8325 of 5 stars
$10.79
-0.1%
$21.00
+94.6%
N/A$3.65B$637.77M0.00N/ANews Coverage
ACAD
ACADIA Pharmaceuticals
3.9087 of 5 stars
$20.94
+0.2%
$29.12
+39.1%
+47.3%$3.53B$957.80M15.74510Analyst Forecast
QURE
uniQure
2.6033 of 5 stars
$63.92
+10.2%
$71.75
+12.2%
+800.9%$3.51B$27.12M-16.31500
ADMA
ADMA Biologics
3.6858 of 5 stars
$14.69
+2.3%
$27.67
+88.3%
-3.3%$3.51B$426.45M17.08530Positive News

Related Companies and Tools


This page (NASDAQ:MNMD) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners